Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...

Feb 18 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up ...

A lethal form of bird flu, which has already killed tens of thousands of elephant seals in the Southern Hemisphere, is now spreading in a colony of elephant seals in California, scientists announced ...

Moderna's shares close up 6% Moderna to conduct post-marketing study in older adults FDA decision expected by August 5 Feb 18 (Reuters) - Moderna said on Wednesday the U.S. Food and Drug ...

This winter’s flu season isn’t over yet, but global health authorities are already preparing for the next one. Last week the World Health Organization (WHO) announced which strains it recommends that ...

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) Feb 18 (Reuters) - A two-in-one mRNA vaccine developed by Moderna that targets ...

The whiplash over a new potential flu vaccine from Moderna, which went from rejected to approved for review in a matter of days, has illustrated a new reality plaguing the Cambridge biotech company ...

Feb 18 (Reuters) - Moderna said on Wednesday the U.S. Food ⁠and ⁠Drug Administration changed course and will review an amended ⁠application for its new flu vaccine, a week after rejecting the original ...

The administration had cut crucial funding for mRNA-based therapies. The rest of the world might step in and benefit.

Feb 13 (Reuters) - Moderna said it is looking for growth overseas after the U.S. FDA refused to review its experimental flu shot and the country's top health officials have deprioritized vaccination.